Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Handbook of Experimental Pharmacology|February 6, 2021
Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid AddictionCatherine M Cahill, Lindsay Lueptow, Hannah Kim, et al.
Scientific Reports|March 2, 2025
[18F]FDG-PET and [18F]MPPF-PET are brain biomarkers for the creatine transporter Slc6a8 loss of function mutationIsabel Day, Mikayla Tamboline, Lindsay Lueptow, et al.
Pain Reports|March 11, 2021
Effects of inflammatory pain on CB1 receptor in the midbrain periaqueductal grayAdrianne R Wilson-Poe, Beth Wiese, Cherkaouia Kibaly, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2020
Biased signaling by endogenous opioid peptidesIvone Gomes, Salvador Sierra, Lindsay Lueptow, et al.
Current Pharmaceutical Design|August 28, 2014
The roles of phosphodiesterase 2 in the central nervous and peripheral systemsChong Zhang, Yingcong Yu, Lina Ruan, et al.
Brain Research|May 26, 2022
Mice heterozygous for a null mutation of CPE show reduced expression of carboxypeptidase e mRNA and enzyme activity but normal physiology, behavior, and levels of neuropeptidesLloyd D Fricker, Mariana Lemos Duarte, Andrei Jeltyi, et al.
Pain|May 15, 2025
Chronic pain selectively reduces the motivation to work for remifentanil but not food rewardLindsay Lueptow, Leeza Shashkova, Emma Twombly, et al.
Pain|August 21, 2025
Chronic pain selectively reduces the motivation to work for remifentanil but not food rewardLindsay Lueptow, Leeza Shashkova, Emma Twombly, et al.
Molecular Therapy. Nucleic Acids|March 14, 2025
Use of an oversized AAV8 vector for CPS1 deficiency results in long-term survival and ammonia controlTaryn Diep, Wesley Zhou, Rachel E Reyes, et al.
Disease Models & Mechanisms|May 27, 2025
A hypomorphic model of CPS1 deficiency for investigating the effects of hyperammonemia on the developing nervous systemStuti Bakshi, Taryn Diep, Brandon J Willis, et al.
Pageof 2